From: Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation
Parameters for comparison
Proposed method
Reported method
Assay
98.85%
99.14%
% Recovery
99.44–100.49
98.80–99.28